Insilicos Announces Appointment of Jeff Howbert as Senior Scientist
Seattle, 15 December 2010 - Insilicos announced today the company has appointed Dr. Jeff Howbert to the role of Senior Scientist. Dr. Howbert is a computer scientist and chemist, with particular interests in statistics, machine learning, and predictive models. He has a longstanding association with Insilicos, working with the company on several research projects. Dr. Howbert brings over 25 years experience in drug discovery and gene discovery in multiple therapeutic areas, in both large pharmaceutical and biotech environments.
"Dr. Howbert is an accomplished and imaginative reearcher," said Insilicos President Erik Nilsson. "It is my pleasure to announce this role for Jeff, a capable scientist whose research interests are well-aligned with Insilicos' direction."
Insilicos LLC is a biomarker discovery and diagnostic development company, concentrating on cardiovascular disease.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' 'PreClue," and 'Life Science Software' are trademarks of Insilicos LLC.
